Form 4: UGI Subsidiary President Exercises, Sells Shares
Insider Transaction Report
Hans G. Bell, President of a UGI Corp subsidiary, exercised stock options and subsequently sold an equal number of shares on November 26, 2025.
Summary
- Hans G. Bell, President of a UGI Corp subsidiary, exercised 11,300 stock options at a price of $33.76 per share on November 26, 2025.
- Immediately following the exercise, Bell sold 11,300 shares of UGI Common Stock at an average price of $38.9114 per share, with prices ranging from $38.90 to $38.9950.
- The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-arranged schedule for the sale of securities.
- After these transactions, Bell directly owns 18,220 shares of UGI Common Stock.
- An additional 1,642 shares of UGI Common Stock are held indirectly by the Hans G. Bell and Melissa A. Bell Trust, where the reporting person's spouse holds shared voting and investment power.
- Bell also holds various unexercised stock options, performance units, and stock units under the UGI Corporation 2021 Incentive Award Plan.
Sentiment
Score: 6
Explanation: The transaction is a routine insider sale following option exercise, executed under a 10b5-1 plan. While a sale reduces direct ownership, the profit realized is positive for the executive, and the pre-planned nature mitigates negative sentiment. It does not indicate a strong positive or negative outlook for the company itself.
Positives
- The exercise of options indicates the reporting person capitalized on vested equity compensation, realizing a profit from the difference between the exercise and sale prices.
- The sale price of $38.9114 is higher than the exercise price of $33.76, resulting in a gain for the reporting person.
- The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned and systematic approach to managing equity compensation, which can mitigate concerns about opportunistic insider trading.
Negatives
- The sale of shares by a key executive, even if pre-planned, could be interpreted by some investors as a reduction in direct equity exposure, potentially signaling a lack of confidence, although it is a common practice for diversification or liquidity.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Section 16 Officer | NA | Hans G. Bell | 2025-01-31 | Re-appointment as Section 16 Officer. |
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be viewed neutrally or slightly negatively, as it reduces the executive's direct stake, but the pre-planned nature under Rule 10b5-1 often mitigates concerns. The profit realized by the executive is a personal financial event.
- Management: The transaction reflects the executive's management of personal equity compensation.
Key Dates
| Date | Description |
|---|---|
| 2017-01-01 | Grant date for options with $46.08 exercise price. |
| 2017-05-01 | Grant date for options with $49.94 exercise price. |
| 2018-01-01 | Grant date for options with $46.95 exercise price. |
| 2019-01-01 | Grant date for options with $33.76 and $53.35 exercise prices; options with $46.08 exercise price became fully vested. |
| 2020-01-01 | Grant date for options with $45.16 exercise price; options with $49.94 exercise price became fully vested. |
| 2020-09-01 | Reporting person was a Section 16 Officer until 2021. |
| 2021-01-01 | Grant date for options with $34.96 exercise price; options with $46.95 exercise price became fully vested. |
| 2022-01-01 | Grant date for options with $45.91 exercise price; options with $33.76 and $53.35 exercise prices became fully vested. |
| 2023-01-01 | Options with $45.16 exercise price became fully vested. |
| 2023-01-12 | Grant date for options with $41.45 exercise price, performance units, and stock units. |
| 2024-01-01 | Grant date for options with $24.60 exercise price, performance units, and stock units; options with $34.96 exercise price became fully vested; first vesting installment for options granted January 12, 2023. |
| 2025-01-01 | Grant date for performance units and stock units; options with $45.91 exercise price became fully vested; first vesting installment for options granted January 1, 2024. |
| 2025-01-31 | Reporting person became a Section 16 Officer again. |
| 2025-11-26 | Date of option exercise and subsequent share sale. |
| 2025-12-01 | Signature date of the filing. |
| 2025-12-31 | Expiration date for options with $33.76 exercise price and performance units granted January 12, 2023. |
| 2026-09-30 | Expiration date for some performance units granted January 1, 2024. |
| 2026-12-31 | Expiration date for options with $46.08 exercise price and some performance units granted January 1, 2024. |
| 2027-04-30 | Expiration date for options with $49.94 exercise price. |
| 2027-12-31 | Expiration date for options with $46.95 exercise price and performance units granted January 1, 2025. |
| 2028-12-31 | Expiration date for options with $53.35 exercise price. |
| 2029-12-31 | Expiration date for options with $45.16 exercise price. |
| 2030-12-31 | Expiration date for options with $34.96 exercise price. |
| 2031-12-31 | Expiration date for options with $45.91 exercise price. |
| 2033-01-11 | Expiration date for options with $41.45 exercise price. |
| 2033-12-31 | Expiration date for options with $24.60 exercise price. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where an executive exercised stock options and immediately sold the acquired shares under a pre-arranged 10b5-1 plan. Such transactions are common for liquidity, diversification, or tax planning and do not typically signal a change in the company's fundamental outlook or performance. The executive still retains a significant number of shares and other derivative securities. Therefore, this specific filing alone does not provide a strong basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate, pending further company-specific or market-wide developments.
Keywords
UGI Corp, UGI, Form 4, Insider Trading, Stock Options, Equity Compensation, Hans G. Bell, Share Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.